COVID-19 SARS-COV-2 INFECTION
Clinical trials for COVID-19 SARS-COV-2 INFECTION explained in plain language.
Never miss a new study
Get alerted when new COVID-19 SARS-COV-2 INFECTION trials appear
Sign up with your email to follow new studies for COVID-19 SARS-COV-2 INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Personalized immune cell therapy aims to clear stubborn COVID-19 infections
Disease control CompletedThis study tests a treatment called LB-DTK-COV19, made from a patient's own immune cells, for people who have had COVID-19 symptoms or a positive test for more than 21 days. Participants receive two infusions of their personalized T cells, two weeks apart, and are followed for si…
Matched conditions: COVID-19 SARS-COV-2 INFECTION
Phase: NA • Sponsor: LucasBio • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Brain fog breakthrough? simple supplement boosts memory in long COVID
Symptom relief CompletedThis study tested whether a daily whey protein supplement called Immunocal could help with memory and attention problems after COVID-19. 120 adults with mild to moderate cognitive issues were split into three groups: Immunocal, cognitive rehab workshops, or no treatment. After 12…
Matched conditions: COVID-19 SARS-COV-2 INFECTION
Phase: NA • Sponsor: Universidad Libre seccional Cali • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
New ibuzatrelvir tablet put to the test in healthy volunteers
Knowledge-focused CompletedThis early-stage study is testing a new tablet version of the COVID-19 drug ibuzatrelvir in 18 healthy adults. Researchers want to see how much of the drug gets into the blood when taken as a whole tablet, dispersed in water, or with food. The goal is to compare the new tablet to…
Matched conditions: COVID-19 SARS-COV-2 INFECTION
Phase: PHASE1 • Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC